Teva Pharmaceutical Investments Singapore, A Subsidiary Of Teva Pharmaceutical Industries And Jiangsu Nhwa Pharmaceutical Formed A Partnership To Market And Distribute Teva's Austedo (Deutetrabenazine) For Neurodegenerative And Movement Disorders
Shanghai Pharmaceuticals Holding Co., Ltd Goes Ex Dividend on Monday
Trevena Receives Milestone Payment From Partner in China Jiangsu Nhwa Pharmaceutical
INNOVATE Corp's MediBeacon Receives $10M In Amended Agreements With Huadong Medicine
Trevena Announces Submission Of New Drug Application In China For OLINVYK By Its Partner Jiangsu Nhwa Pharmaceutical
Jiangsu Nhwa Pharma Signs Nearly $18 Million Deal to License Lundbeck’s Schizophrenia Drug